Middle-Aged Adults Taking GLP-1s Could Cut Medical Costs
A fresh health-economics study links the use of GLP-1 obesity drugs to sizable lifetime medical cost reductions for 4...
Explore what constitutes a leading economic indicator, why it matters, and how analysts use it to anticipate shifts in the economy.
10,046 articlesA fresh health-economics study links the use of GLP-1 obesity drugs to sizable lifetime medical cost reductions for 4...
Marvell is signaling rapid growth in its custom chips for AI accelerators. This article breaks down the forecast, wha...
Bitcoin fans have watched a calm stretch emerge around the $60,000 mark. This article breaks down what that steady vi...
RFK Jr. backs a plan to immediately hike payroll taxes to close Social Security's funding gap, triggering political d...
A SpaceX AI push could rewrite how we think about tech bets. If spacex just spent billion, investors should watch how...
Quantum stocks jump on optimism about next-gen tech, yet analysts caution that lofty valuations outpace current earni...
Investors wonder about the path ahead for Lucid stock. This guide lays out three scenarios, the key drivers, and conc...
New housing data show wages growing faster than home prices, signaling improving affordability. Borrowers may see ste...
When the market falters, smart investors pivot to high-quality names. This guide outlines five durable stocks to buy ...
New York billionaire Bill Ackman launches a $260 million brain research center on the Upper West Side after a family ...
Alta Fox quietly increases its XPEL exposure, lifting the stake to about 15.5% after a roughly $58 million purchase. ...
Alphabet stock moved higher in a week driven by AI chip ambitions, cloud momentum, and a resilient ad business. This ...